DHAIS, the Cardiff company which owns the Hearing Health and Mobility (HHML) retail business, has upped sales close to £10m in its 13th year of trading. In the year to 30 June 2014, the business reported turnover of £9.6m and a profit of ... Insider Media Limited, 2 weeks ago
Merck & Co Inc said on Monday it would buy Cubist Pharmaceuticals Inc in a deal valued at $9.5 billion, giving the major drugmaker an entry into the market for drugs that target so-called superbugs. Merck and British rival AstraZeneca Plc have ...FOXBusiness.com, 1 week ago Merck to take on superbugs with Cubist Pharma buy Sharenet, 1 week ago Merck takes aim at superbugs, to buy Cubist in $9.5 bln deal Sharenet, 1 week ago UPDATE 4-Merck to take on superbugs with Cubist Pharma buy Reuters UK, 1 week ago
More from: Reuters UK, Reuters UK...and 4 other sources
28th November 2014 08:14 DHAIS swung into the black in the year to the end of June as the group's business and activities progressed in line with expectation. Turnover rose to £9.6m - up from £7.9m - and the group reports a pofit of £161,000 ...This is Money, 3 weeks ago
DHAIS Plc ("DHAIS" or the "Company") Final Results for the year ended 30 June 2014 Chairman's Statement I am pleased to report on our thirteenth year of trading and our sixth year as an ISDX Growth Market listed company. Results The group's business ...MoneyAM, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!